Mylan pulls EU application for generic Taxotere | Reuters
Links shared publicly online about this topic.
- 1,313total visits
Mylan pulls EU application for generic Taxotere | Reuters
LONDON, March 15 (Reuters) - Mylan has withdrawn its application to market a generic version of Sanofi-Aventis's cancer drug in Europe, after adverse feedback from regulators.
View full resource at reuters.com
Tags: Cancer, Cancer Medication, Drug, Taxotere, Sanofi-Aventis
Most Recently Shared on March 15, 2010 at 12:58 pm By:
Reuters: Mylan pulls EU application for generic #Taxotere. http://bit.ly/a0UhNE
Advertisement
